Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT1 receptor antagonist telmisartan
IntroductionTreatment of rodents with the AT1 blocker (ARB) telmisartan (TEL) has an anti-adipose effect. Among other mechanisms, we also have attributed the anti-adipose action to diet-independent alterations in gut microbiota. Thus, we aimed here to confirm this mechanism by using the fecal microb...
Saved in:
Main Authors: | Marco L. Freschi (Author), Axel Künstner (Author), Gianna Huber (Author), Ines Stölting (Author), Hauke Busch (Author), Misa Hirose (Author), Walter Raasch (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice
by: Laura Nickel, et al.
Published: (2022) -
Electrical-field sensitive YBa?Cu?O??? detectors for real-time monitoring of picosecond THz pulses
by: Raasch, Juliane
Published: (2019) -
Management of superficial basal cell carcinoma: focus on imiquimod
by: Beverly Raasch
Published: (2009) -
The brain-protective mechanism of fecal microbiota transplantation from young donor mice in the natural aging process via exosome, gut microbiota, and metabolomics analyses
by: Longfei Lin, et al.
Published: (2024) -
Epistemologia e ontologia em Paulo Freire
by: Patricia Tatiana Raasch, et al.
Published: (2023)